Stabilized Cysteamine 5% Cream for the Treatment of Senile Lentigo

Main Article Content

Nasrin Saki

Keywords

cysteamine, senile lentigo

Abstract

N/A

References

1. Besouw, M, and al. (2013). "Cysteamine: an old drug with new potential". Drug Discovery Today. 18
(15-16): 785–792. https://doi.org/10.1016/j.drudis.2013.02.003

2. Chavin, W.; Schlesinger, W. (1966). "Some potent melanin depigmentary agents in the black
goldfish". Die Naturwissenschaften 53(16): 413–414. https://doi.org/10.1007/BF00625789

3. Mansouri, P and al. (2015)."Evaluation of the efficacy of cysteamine 5% cream in the treatment of
epidermal melasma: a randomized double-blind placebo-controlled trial". The British Journal of
Dermatology. 173 (1): 209–21. https://doi.org/10.1111/bjd.13424

4. Farshi et al. (2018). ”Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating
by Dermacatch : a randomized double blind placebo controlled study”. J. Dermatol. Treat. 29:2, 182-
189. https://doi.org/10.1080/09546634.2017.1351608


5. Fitzpatrick and al. (1968). "Selective action of mercaptoethylamines on melanocytes in mammalian
skin: experimental depigmentation". Arch Dermatol 97:465–77 10.

6. Nguyen et al. (2020). “Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the
treatment of melasma: A randomised, double-blinded trial” Aust. J.
Dermatol. https://doi.org/10.1111/ajd.13432

7. Kasraee et al. (2019). “Significant therapeutic response to cysteamine cream in a melasma patient
resistant to Kligman's formula”. J Cosmet Dermatol. 18(1):293-295.
https://doi.org/10.1111/jocd.12837

8. Karrabi et al. (2020). “Clinical evaluation of efficacy, safety and tolerability of cysteamine 5% cream in
comparison with modified Kligman’s formula in subjects”, Skin Res Technol.
https://doi.org/10.1111/srt.12901

9. Karrabi, and al. (2020). ”Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in
comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized
clinical trial study”. Arch Dermatol Res. https://doi.org/10.1007/s00403-020-02133-7

10. Mathe, Balogun, Yoo. (2021). “A case report on the use of topical cysteamine 5% cream in the
management of refractory postinflammatory hyperpigmentation (PIH) resistant to triple combination
cream (hydroquinone, topical corticosteroids, and retinoids)”. J Cosmet Dermatol. ; 20: 204-
206. https://doi.org/10.1111/jocd.13755

11. James WD and al. (2011). “Andrew’s Diseases of the Skin E-Book: Clinical dermatology” Elsevier Health Sciences

12. Šitum M and al. (2010). “Senile lentigo–cosmetic or medical issue of the elderly population”. Collegium
antropologicum. 34(2):85-8.

13. Taylor A and al. (2008). “Prevalence of pigmentary disorders and their impact on quality of life: a
prospective cohort study”. J Cosmet Dermatol. Sep;7(3):164-8. https://doi.org/10.1111/j.1473- 2165.2008.00384.x 14. Kligman, A. M., & Willis, I. (1975). “A new formula for depigmenting human skin. Archives of dermatology, 111(1), 40-48. doi:10.1001/archderm.1975.01630130042004